Evidence map›Paper›PMID 27707834›Full record

Trial reportBMJ open2016

Cohort feasibility study of an intermittent pneumatic compression device within a below-knee cast for the prevention of venous thromboembolism.

Irene Braithwaite, Bernadette De Ruyter, Alex Semprini, Stefan Ebmeier, Grant Kiddle, Nigel Willis, John Carter, Mark Weatherall, Richard Beasley

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Irene BraithwaiteMedical Research Institute of New Zealand, Wellington, New Zealand Capital and Coast District Health Board, Wellington, New Zealand.ORCID 0000-0001-5327-3027
Bernadette De RuyterCapital and Coast District Health Board, Wellington, New Zealand.
Alex SempriniMedical Research Institute of New Zealand, Wellington, New Zealand.
Stefan EbmeierMedical Research Institute of New Zealand, Wellington, New Zealand.
Grant KiddleCapital and Coast District Health Board, Wellington, New Zealand.
Nigel WillisCapital and Coast District Health Board, Wellington, New Zealand.
John CarterCapital and Coast District Health Board, Wellington, New Zealand.
Mark WeatherallUniversity of Otago Wellington, Wellington, New Zealand.
Richard BeasleyMedical Research Institute of New Zealand, Wellington, New Zealand Capital and Coast District Health Board, Wellington, New Zealand.
Capital and Coast District Health Board · NZMedical Research Institute of New Zealand · NZUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the likely enrolment rate of eligible participants into a randomised controlled trial (RCT) in which a within-cast intermittent pneumatic compression device using Jet Impulse Technology (IPC/JIT) is 1 of 3 possible interventions in a RCT for the prevention of venous thromboembolism (VTE) in the clinical setting of isolated lower limb cast immobilisation.

designA prospective, open-label feasibility study of the IPC/JIT device placed within a lower limb cast.

settingWellington Regional Hospital Fracture Clinic.

participantsIndividuals aged 18-70 who presented with a lower limb injury requiring a minimum of 4 weeks below-knee cast immobilisation.

interventionPlacement of an IPC/JIT device within lower limb cast. OUTCOME MEASURES: The main outcome measure was the proportion of eligible participants who participated in the feasibility study. Secondary outcome measures included adherence to device usage throughout the study, ease of application of the device and adverse events potentially associated with its use.

resultsThe proportion of potentially eligible participants for the IPC/JIT device was only 7/142 (5%), 95% CI 2 to 9.9. Devices were used for a mean (range) of 4.1 (1.9 to 10.2) hours per day and none of 7 participants had adequate adherence to the device. 3 of the 7 participants suffered an adverse event, including 1 deep vein thrombosis, 2 dorsal foot ulcer and 1 skin maceration.

conclusionsA within-cast IPC/JIT device is unlikely to be a feasible randomisation arm for a RCT assessing possible interventions for the reduction of VTE risk in the clinical setting of lower limb injury requiring below knee cast immobilisation for a minimum of 4 weeks. TRIAL REGISTRATION NUMBER: ANZCTR 12615000192583.

Indexed as

Intermittent Pneumatic Compression DevicesPatient CompliancePatient SelectionAdolescentAdultAgedFeasibility StudiesFemaleHumansImmobilizationKneeLower ExtremityMaleMiddle AgedProspective StudiesVenous ThromboembolismVASCULAR MEDICINE

Identifiers

PMID27707834
PMCPMC5073634
OpenAlexW2529505613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.